Here's What You'll Learn:

• Review mechanisms for aging as a whole and age-related diseases broadly
• Evaluate data thus far from completed animal and human trials on sirolimus (rapamycin) and aging as well as safety
  Briefly review the landscape of pharmaceutical interventions for age-related diseases (ex: metformin)
• Discuss upcoming RAPID clinical trial and study design
• Discuss proposed mechanisms of action of sirolimus (rapamycin) for mitigation of age-related diseases